Your fact-checks will appear here
Bill Gates’ involvement in Alzheimer’s research through funding and initiatives since 2020
The short answer: has publicly supported several activities and investments aimed at improving, preserving, or understanding the mind — from recommending books about mindset to funding and backing bra...
There is no evidence in the supplied reporting that has endorsed a product or program called “”; the sources instead document Gates recommending the book , investing in , and writing about his reading...
has not been shown, in the reporting provided, to have publicly recommended or licensed his name to any consumer “smart pill” or cognitive supplement product; instead, marketers have repeatedly used h...
–backed initiatives and investments favor a pluralistic, translational approach to Alzheimer’s therapeutics that explicitly includes small molecules and biologics but emphasizes newer mechanisms—mitoc...
has repeatedly committed large sums to and through direct investments and philanthropy — including a $50M investment in the , a $10M award to the “Part the Cloud” program , substantial commitments to ...
boosts his mind through structured solitude, regular reading, short sessions, and philanthropic investment in brain science—practices he credits with improving focus and inspiring ideas like products ...
There is no credible evidence in the reporting provided that created, marketed or formally endorsed a product called “”; sources instead document a recurring scam tactic of falsely attaching Gates’ na...
Bill Gates personally committed roughly $100 million to Alzheimer’s and dementia efforts beginning in 2017, and the bulk of that money has gone to drug discovery, diagnostics and venture-style investm...
has committed personal and philanthropic capital to multiple Alzheimer’s initiatives that target early detection, diagnostics, data sharing and therapeutic pipelines, including multi‑million‑dollar in...
has directed a mix of personal and philanthropic capital into Alzheimer’s research across venture-style funds, initiatives, data-sharing efforts and targeted grants—most prominently a stake in the , a...
has become a major private funder and public advocate in the fight against Alzheimer’s, committing hundreds of millions through donations, targeted grants, and new investment vehicles aimed at early d...
The Mind Booster" story is not legitimate: multiple reputable consumer-protection and news outlets have documented that marketers of so-called "smart pill" supplements falsely attribute endorsements t...
’ publicly discussed “mind-boost” habits are mundane, science-aligned practices—reading, sleep and low-effort tasks that encourage mental wandering—combined with large-scale investment in brain scienc...
does fund and publicly promote serious research aimed at diagnosing, treating and better understanding brain disease — including large donations to dementia funds, diagnostic accelerators and technolo...
There is no credible evidence that personally uses or publicly endorses a “” drug; the record shows sizable investments by Gates into and brain‑disease research, diagnostics and biotech companies rath...
has shifted significant personal and philanthropic capital into efforts to detect, understand and ultimately prevent Alzheimer’s disease, backing diagnostics, data platforms and drug-discovery funds w...
(through philanthropic commitments and his private office, ) has backed multiple that explicitly target Alzheimer’s diagnostics and platforms — notably (a $100M diagnostics fund) and the Alzheimer’s D...
is not running laboratory benches or clinical trials himself but has funneled substantial philanthropic capital and organizational muscle into , prioritizing , early detection and diagnostics, and nov...